273 related articles for article (PubMed ID: 21606286)
1. Renal cell carcinoma: what the surgeon and treating physician need to know.
Chapin BF; Delacroix SE; Wood CG
AJR Am J Roentgenol; 2011 Jun; 196(6):1255-62. PubMed ID: 21606286
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma: diagnosis, staging, and surveillance.
Ng CS; Wood CG; Silverman PM; Tannir NM; Tamboli P; Sandler CM
AJR Am J Roentgenol; 2008 Oct; 191(4):1220-32. PubMed ID: 18806169
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of large renal tumors.
Wszolek MF; Wotkowicz C; Libertino JA
Nat Clin Pract Urol; 2008 Jan; 5(1):35-46. PubMed ID: 18185512
[TBL] [Abstract][Full Text] [Related]
4. NCCN clinical practice guidelines in oncology: kidney cancer.
Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
J Natl Compr Canc Netw; 2009 Jun; 7(6):618-30. PubMed ID: 19555584
[No Abstract] [Full Text] [Related]
5. Multimodality treatment of metastatic renal cell carcinoma.
Mickisch GH
Expert Rev Anticancer Ther; 2002 Dec; 2(6):681-5. PubMed ID: 12503214
[TBL] [Abstract][Full Text] [Related]
6. [Not Available].
Aktuelle Urol; 2015 Nov; 46(6):430. PubMed ID: 26599942
[No Abstract] [Full Text] [Related]
7. Metastatic renal cell carcinoma: systemic treatment.
Abi-Aad AS; deKernion JB
Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
[No Abstract] [Full Text] [Related]
8. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
9. [Update uro-oncology: scientific meetings 2011].
Hegele A; Skrobek L; Schrader AJ
Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
11. Renal masses: urologic management.
Ornstein DK; Arcangeli CG; Andriole GL
Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):1-12. PubMed ID: 8995121
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
13. [German Renal Cell Tumors Network].
Junker K; Wunderlich H; Steiner T; Hartmann A; Schubert J
Urologe A; 2007 Sep; 46(9):1166. PubMed ID: 17676297
[No Abstract] [Full Text] [Related]
14. Late recurrences of renal cell carcinoma at unusual sites: implications for patient management.
Venugopal B; Evans TR
Clin Adv Hematol Oncol; 2012 Feb; 10(2):126-8. PubMed ID: 22402358
[No Abstract] [Full Text] [Related]
15. Collecting duct renal cell carcinoma: two different clinical stages, two different clinical outcomes.
Vázquez-Lavista LG; Uribe-Uribe N; Gabilondo-Navarro F
Urol Int; 2008; 81(1):116-8. PubMed ID: 18645283
[TBL] [Abstract][Full Text] [Related]
16. The expanding role of imaging in the management of renal cell carcinoma.
Murphy G; Jhaveri K
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1871-88. PubMed ID: 22117155
[TBL] [Abstract][Full Text] [Related]
17. [Guideline 'Renal cell carcinoma'].
Mulders PF; Brouwers AH; Hulsbergen-van der Kaa CA; van Lin EN; Osanto S; de Mulder PH
Ned Tijdschr Geneeskd; 2008 Feb; 152(7):376-80. PubMed ID: 18380384
[TBL] [Abstract][Full Text] [Related]
18. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
Gupta SK; Vogelzang N
Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
[No Abstract] [Full Text] [Related]
19. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Escudier B; Kataja V;
Ann Oncol; 2010 May; 21 Suppl 5():v137-9. PubMed ID: 20555064
[No Abstract] [Full Text] [Related]
20. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
Köpke T; Bierer S; Wülfing C; Tiemann A; Hertle L; Herrmann E
Expert Rev Anticancer Ther; 2009 Jun; 9(6):763-71. PubMed ID: 19496713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]